GlucoTrack, Inc. (GCTK)
GlucoTrack, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Rutherford, NJ, US. The stock last traded at $0.38, up 3.32% on the session, giving a market capitalisation of $3.0M. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of 0.0%. Its beta of 0.66 implies it has historically moved less than the broad market.
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. is most often compared with the following Healthcare names: